ARE YOU READY?
Tough Questions
If you answer YES to any of these questions, then you would gain confidence from the Sentero Pharma approach
ARE YOU READY?
DO YOU KNOW the details behind the epidemiology figures you reference and how they might misstate potential?
KEY ISSUE: Typical epidemiology studies are not designed to support commercial forecasting.
DO YOU UNDERSTAND how key market segments, such as patient ago/type and anticipated payer coverage of studied vs. non-studied populations might impact clinical trial design and commercial potential for your indication?
KEY ISSUE: Critical to identify the addressable patient populations from study protocol through approved PI.
CAN YOU EXPLAIN what happened to the “other half” of market share when you were advised to model market share by simply cutting physician preference share by 50%?
KEY ISSUE: Structured and defensible share calibration is necessary for an accurate forecast.
ARE YOU CONTEMPLATING how pricing dynamics may impact market share and patient access?
KEY ISSUE: Proper design of payer market research, analogue selection & value framework supports effective pricing.
ARE YOU CONFIDENT that projecting ex-US potential by simply applying the “25% rule of thumb” accurately represents your asset’s potential?
KEY ISSUE: Credibly assert of ex-US projections even at early development stage.